International Coal Group to Present at Raymond James Coal Investors Conference -
Elkhart mine expansion to benefit region and local economy -
iCo Therapeutics Oral Amphotericin B Poster at AAPS -
iCo Therapeutics Third Quarter Financial Results -
Mine operation looking to tap into Lincoln/Logan Enterprise Zone -
Residents to have improved road in Eccles -
iCo Therapeutics Oral Amphotericin B Effective Against Visceral Leishmaniasis -
International Coal Group Reports Third Quarter 2008 Results -
ICO: Q3 Earnings Call @ 11:00 ET Today [delayed] -
International Coal Group Announces Third Quarter 2008 Earnings Release and Conference Call -
iCo Therapeutics Provides iCo-009 (Oral Amphotericin B) Pharmacokinetic Results -
JEFFERIES STARTS INTERNATIONAL COAL GROUP WITH BUY RATING; PRICE TARGET OF $8 -
UBS CUTS INTERNATIONAL COAL GROUP PRICE TARGET TO $14 FROM $16; RATING BUY -
14th Senate seat candidates weigh in on issues -
iCo Therapeutics Selected as Canada's Top 10(TM) Competition Winner -
iCo Therapeutics to Present at BioContact Québec -
iCo Therapeutics Provides Interim Trial Results (Diffuse Diabetic Macular Edema) -
ICO: To Present At Davenport Metals and Mining Conference @ 07:45 ET [delayed] -